MedTrace Logo

INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

NCT04932148 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2026-05-13

No results posted yet for this study

Summary

The INCH-HD trial will test if incremental HD preserves the quality of life of patients and families and is a safe, practical, cost effective treatment option.

Conditions

Interventions

OTHER

Incremental HD

Starting haemodialysis at twice weekly frequency

OTHER

Conventional HD

Starting haemodialysis at thrice weekly frequency

Sponsors & Collaborators

  • Medical Research Future Fund

    collaborator OTHER

  • Queensland Health

    collaborator OTHER_GOV

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • The University of Queensland

    lead OTHER

Principal Investigators

  • Peter Kerr, Prof · University of Queensland, Monash University

  • David Johnson, Prof · University of Queensland, Queensland Health

  • Andrea Viecelli, Dr · University of Queensland, Queensland Health

  • Charmaine Lok, Prof · University Health Network, Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-06
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932148 on ClinicalTrials.gov